Fig. 1From: Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocolTimeline for study procedures and visits for the main study (a) and innate sub-study (b). Abbreviations: RZV, recombinant zoster virus; D, dayBack to article page